HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Geoffrey A Donnan Selected Research
Geoffrey A Donnan Research Topics
Disease
158
Stroke (Strokes)
03/2024 - 01/2002
108
Ischemic Stroke
03/2024 - 01/2002
27
Infarction (Infarctions)
01/2022 - 01/2002
13
Hemorrhage
01/2023 - 01/2010
9
Cerebral Hemorrhage
03/2022 - 06/2006
8
Intracranial Hemorrhages (Intracranial Hemorrhage)
01/2023 - 09/2008
8
Hypertension (High Blood Pressure)
01/2022 - 02/2002
8
Cerebral Infarction
01/2020 - 01/2002
7
Atrial Fibrillation
10/2019 - 04/2002
6
Hematoma
03/2022 - 11/2013
6
Cardiovascular Diseases (Cardiovascular Disease)
01/2020 - 09/2002
5
Edema (Dropsy)
01/2022 - 08/2013
5
Brain Edema (Cerebral Edema)
01/2022 - 08/2013
5
Ischemia
08/2018 - 05/2004
4
Arterial Occlusive Diseases (Arterial Occlusive Disease)
01/2022 - 01/2014
4
Dementia (Dementias)
01/2021 - 10/2004
4
Brain Ischemia (Cerebral Ischemia)
05/2012 - 01/2008
3
Thrombosis (Thrombus)
01/2023 - 01/2018
3
Carotid Stenosis (Carotid Artery Stenosis)
10/2019 - 01/2004
3
Body Weight (Weight, Body)
01/2018 - 03/2015
3
Transient Ischemic Attack
01/2017 - 05/2012
3
Cognitive Dysfunction
01/2017 - 10/2008
3
Hypoxia (Hypoxemia)
03/2011 - 07/2006
2
Hyperglycemia
12/2023 - 01/2019
2
Hemorrhagic Stroke
01/2023 - 01/2021
2
Chronic Renal Insufficiency
11/2022 - 01/2021
2
Inflammation (Inflammations)
01/2016 - 01/2006
2
Embolism (Embolus)
05/2014 - 04/2012
2
Hypothermia
08/2013 - 12/2007
2
Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
03/2011 - 09/2003
1
Vomiting
12/2023
1
Hypoglycemia (Reactive Hypoglycemia)
12/2023
1
Nausea
12/2023
1
COVID-19
05/2022
1
Frailty
01/2021
1
Wounds and Injuries (Trauma)
12/2020
1
Intracranial Thrombosis (Cerebral Thrombosis)
01/2020
1
Neurologic Manifestations (Neurological Manifestations)
01/2019
Drug/Important Bio-Agent (IBA)
65
Tissue Plasminogen Activator (Alteplase)
FDA Link
03/2024 - 01/2005
19
Aspirin (Acetylsalicylic Acid)
FDA Link
Generic
01/2023 - 05/2004
18
Tenecteplase
FDA Link
01/2023 - 01/2014
14
Biomarkers (Surrogate Marker)
IBA
01/2022 - 04/2004
9
Neuroprotective Agents
IBA
08/2018 - 05/2004
6
Cytidine Triphosphate (CTP)
IBA
10/2018 - 01/2008
6
Warfarin (Coumadin)
FDA Link
Generic
05/2014 - 05/2004
5
Antihypertensive Agents (Antihypertensives)
IBA
01/2020 - 08/2013
5
fluoromisonidazole
IBA
03/2011 - 02/2004
4
Tranexamic Acid (AMCA)
FDA Link
03/2022 - 06/2014
4
Cholesterol
IBA
10/2019 - 02/2002
4
Clopidogrel (Plavix)
FDA Link
05/2014 - 11/2004
3
Fibrinolytic Agents (Antithrombotic Agents)
IBA
01/2022 - 06/2011
3
Indicators and Reagents (Reagents)
IBA
01/2020 - 08/2018
3
Glucose (Dextrose)
FDA Link
Generic
01/2019 - 12/2014
3
disufenton sodium (NXY 059)
IBA
08/2018 - 08/2006
3
Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)
IBA
01/2018 - 01/2008
3
Angiotensin Receptor Antagonists
IBA
09/2009 - 09/2008
2
Proteins (Proteins, Gene)
FDA Link
01/2020 - 06/2015
2
Complement System Proteins (Complement)
IBA
01/2020 - 01/2016
2
Lipids
IBA
01/2018 - 01/2012
2
ORALIT (ORS)
IBA
07/2017 - 06/2005
2
Glyburide (Glibenclamide)
FDA Link
Generic
08/2014 - 01/2014
2
Amyloid (Amyloid Fibrils)
IBA
05/2012 - 12/2010
2
2- (4'- (methylamino)phenyl)- 6- hydroxybenzothiazole (Pittsburgh compound B)
IBA
05/2012 - 12/2010
2
Desmodus rotundus salivary plasminogen activator alpha 1
IBA
01/2010 - 03/2009
2
Telmisartan (Micardis)
FDA Link
10/2008 - 09/2008
2
Dipyridamole (Persantine)
FDA Link
Generic
10/2008 - 09/2008
2
Platelet Aggregation Inhibitors (Antiplatelet Drugs)
IBA
05/2008 - 01/2008
2
Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)
IBA
01/2008 - 04/2002
2
Perindopril
FDA Link
Generic
06/2003 - 02/2003
2
Heparin (Liquaemin)
FDA Link
Generic
04/2003 - 01/2003
1
Insulin (Novolin)
FDA Link
12/2023
1
Exenatide (Byetta)
FDA Link
12/2023
1
Glucagon-Like Peptide 1 (GLP 1)
IBA
12/2023
1
Fibrin
IBA
05/2022
1
Gadolinium
IBA
01/2022
1
Plasminogen Activators (Plasminogen Activator)
IBA
01/2022
1
Edetic Acid (EDTA)
FDA Link
01/2020
1
Complement C9 (Complement Component 9)
IBA
01/2020
1
Vitronectin
IBA
01/2020
1
Clusterin
IBA
01/2020
1
Dabigatran
FDA Link
01/2019
Therapy/Procedure
74
Therapeutics
01/2024 - 01/2002
33
Thrombectomy
12/2023 - 03/2015
13
Thrombolytic Therapy
06/2016 - 11/2002
10
Secondary Prevention
01/2023 - 02/2003
6
Stents
01/2019 - 03/2015
5
Carotid Endarterectomy
10/2019 - 08/2002
5
Treatment Delay
05/2017 - 04/2014
4
Contraindications
01/2020 - 10/2017
4
Time-to-Treatment
06/2019 - 05/2010
3
Aftercare (After-Treatment)
01/2019 - 07/2013
3
Institutionalization (Institutionalized Persons)
10/2004 - 12/2002
2
Length of Stay
01/2021 - 04/2003
2
Patient Readmission
12/2020 - 07/2015
2
Early Ambulation
11/2020 - 01/2011
2
Catheters
01/2020 - 01/2018
1
Subcutaneous Injections
12/2023
1
Critical Care (Surgical Intensive Care)
09/2021
1
Subacute Care
12/2020
1
Punctures
01/2019